USE OF A RADIOACTIVELY LABELLED MOLECULE SPECIFICALLY BINDING TO ED-B FIBRONECTIN IN A METHOD OF HODGKIN LYMPHOMA.

摘要

The invention relates to the use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment for patients with Hodgkin lymphoma, in particular primary refractory Hodgkin lymphoma or recurrent Hodgkin lymphoma after chemotherapy, and for Hodgkin lymphoma patients scheduled for primary combined modality therapy.